The nucleic acid is particularly useful as a carrier providing a variety of antigens or DNA plasmid vaccine component adenovirus for producing HCV against HCV specific cell-mediated immunity (CMI) reactions.E·A·埃米尼D·C·卡斯罗A·J·贝特...
are the most acute. Recombinant envelope proteins (E1 and E2) have been shown to induce a short-lived specific anti-E1 and E2 response in immunized chimpanzees, and transient protection from challenge with the same virus strain. There is, however, little prospect of an effective vaccine for hu...
发明人: EA Emini,C Stefano,DC Kaslow,JW Shiver,L Armin,AJ Bett,L Alessandra,N Alfredo,C Riccardo 被引量: 31 摘要: $%^&*AU2007231692B820120308.pdf### HEPATITIS C VIRUS VACCINE Abstract The present invention features Ad6 vectors and a nucleic acid encoding a Met-NS3 NS4A-NS4B-NS5A...
Development of an effective vaccine against the hepatitis C virus (HCV) has long been defined as a difficult challenge due to the considerable variability of this RNA virus and the observation that convalescent humans and chimpanzees could be re-infected after re-exposure. On the other hand, ...
Hepatitis C is an inflammation of the liver caused by a specific virus called the hepatitis C virus (HCV). The word "hepatitis" is derived from two Latin segments: "hepat" refers to the liver, and "itis" meaning inflammation. The term "hepatitis" is not specific for a particular cause ...
Hepatitis C virus vaccine design: focus on the humoral immune response Daniel Sepulveda-Crespo Salvador Resino Isidoro Martinez Journal of Biomedical Science (2020) Decremental effect of non-host humoral milieu interfacing viral envelope on the RNA level and surface antigenicity of hepatitis C virus...
(1998). Perspectives for a hepa- titis C virus vaccine. Clin. Diagn. Virol. 10 (2-3), 181- 185.Abrignani, S. & Rosa, D. (1998). Perspectives for a hepatitis C virus vaccine. Clin Diagn Virol 10, 181-185.Abrignani S, Rosa D. Perspectives for a hepatitis C virus vaccine[J]....
Makimura M, Miyake S, Akino N, Takamori K, Matsuura Y, Miyamura T, Saito I, 1996, Induction of antibodies against structural proteins of hepatitis C virus in mice using recombinant adenovirus, Vaccine, 14: 28-34. Mamiya N, Worman HJ, 1999, Hepatitis C virus core protein binds to a DEA...
There’s currently no vaccine to prevent hepatitis C. Here are the best ways to avoid getting hep C: Don't share needles, syringes, or other equipment when injecting drugs. Protect yourself by wearing gloves if you must touch another person's blood or open sores. ...
Researchers have been trying for decades to develop a vaccine against the globally endemic hepatitis C virus (HCV). Now scientists at The Scripps Research Institute (TSRI) have discovered one reason why success has so far been elusive.